Product Certification&
    Enterprise Certification

  • Mr.David
    Tel: 0086-21-18019205509

  • Ms.Thea Deng
    Tel: 18297853543

  • Mobile:18019205509
  • Tel:0086-21-18019205509
  • Fax:0086-21-56469616
  • URL:http://www.minstargroup.com
  • Province/state:Shanghai
  • City:Shanghai
  • Street:BUILDING 8, NO.1098, CHUANSHA ROAD, SHANGHAI, CHINA
  • MaxCard:
Home > Products >  Imatinib mesylate 220127-57-1

Imatinib mesylate 220127-57-1 CAS NO.220127-57-1

  • Min.Order: 0 Metric Ton
  • Payment Terms: T/T,MoneyGram,Other
  • Product Details

Keywords

  • 220127-57-1
  • Imatinib mesylate

Quick Details

  • ProName: Imatinib mesylate 220127-57-1
  • CasNo: 220127-57-1
  • Molecular Formula: C30H35N7O4S
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99%
  • LimitNum: 0 Metric Ton

Superiority

GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE;CGP-57148B;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;STI-571;IMATINIB BASE(IMA-3)

Details


Imatinib mesylate Chemical Properties

mp  214-224°C
storage temp.  -20°C Freezer
CAS DataBase Reference 220127-57-1(CAS DataBase Reference)



Safety Information

Hazardous Substances Data 220127-57-1(Hazardous Substances Data)



MSDS Information 

 



Imatinib mesylate Usage And Synthesis

a small-molecule inhibitor Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans. 
Chemical Properties Off-White Solid
Usage A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)
Usage Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib
Usage Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.
Usage echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog